富血小板血浆联合发散式冲击波治疗足跖筋膜炎的效果评价关冕【Summary】目的：評价富血小板血浆联合发散冲击波治疗足跖筋膜炎的效果。方法：选取2017年10月-2021年1月于沈阳市骨科医院骨科病房住院的67例足底筋膜炎患者作为研究对象。采用随机数字表分组法将其分为对照组（n=32）与试验组（n=35）。对照组采用透明质酸钠联合发散式冲击波治疗，试验组采用富血小板血浆联合发散冲击波治疗。比较两组治疗前、治疗2周后、治疗3个月后数字痛觉评分法（NPRS）评分、踝-后足功能评分系统（AOFAS）评分以及足筋膜厚度。评价两组安全性。结果：治疗2周与3个月后，两组NPRS评分均比治疗前降低，且试验组均低于对照组（P<0.05）。治疗2周与3个月后，两组AOFAS评分均比治疗前升高，且试验组均高于对照组（P<0.05）。治疗前、治疗2周与3个月后，两组足底筋膜厚度比较，差异均无统计学意义（P>0.05）。两组组内治疗前、治疗2周后、治疗3个月后NPRS、AOFAS评分与足底筋膜厚度比较，差异均有统计学意义（P<0.05）。治疗后两组各出现1例（2.98%）足跖部局部肿胀事件。结论：富血小板血浆联合发散冲击波治疗慢性足跖筋膜炎，在缓解疼痛、提高足-踝功能活动发面效果明显且安全性稳定。【Key】富血小板血浆发散式冲击波治疗足跖筋膜炎透明质酸钠EfficacyEvaluationofPlatelet-richPlasmaCombinedwithExtracorporealShockWaveintheTreatmentofPlantarFasciitis/GUANMian.//MedicalInnovationofChina，2022，19（04）：0-077[Abstract]Objective：Toevaluatetheeffectofplatelet-richplasmacombinedwithextracorporealshockwaveinthetreatmentofplantarfasciitis.Method：Atotalof67patientswithplantarfasciitiswhowerehospitalizedintheorthopaedicwardofShenyangOrthopaedicHospitalfromOctober2017toJanuary2021wereselectedastheresearchsubjects.Theyweredividedintocontrolgroup（n=32）andexperimentalgroup（n=35）byrandomnumbertablegroupingmethod.ThecontrolgroupwastreatedwithSodiumHyaluronatecombinedwithextracorporealshockwave，whiletheexperimentalgroupwastreatedwithplatelet-richplasmacombinedwithextracorporealshockwave.Digitalpainscoring（NPRS）score，ankle-posteriorfootfunctionscoringsystem（AOFAS）scoreandfootfasciathicknesswerecomparedbetweenthetwogroupsbeforetreatment，2weeksaftertreatmentand3monthsaftertreatment.Thesafetyofthetwogroupswasevaluated.Result：After2weeksand3monthsoftreatment，NPRSscoresintwogroupswerelowerthanthosebeforetreatment，andthoseinexperimentalgroupwerelowerthanthoseincontrolgroup（P<0.05）.After2weeksand3monthsoftreatment，AOFASscoresinbothgroupswerehigherthanthosebeforetreatment，andthoseinexperimentalgroupswerehigherthanthoseincontrolgroup（P<0.05）.Beforetreatment，2weeksand3monthsaftertreatment，therewerenosignificantdifferencesinplantarfasciathicknessbetweentwogroups（P>0.05）.TherewerestatisticallysignificantdifferencesinNPRS，AOFASscoresandplantarfasciathicknessbetweenthetwogroupsbeforetreatment，2weeksand3monthsaftertreatment（P<0.05）.Aftertreatment，therewas1case（2.98%）oflocalswellingoffootinbothgroups.Conclusion：Platelet-richplasmacombinedwithextracorporealshockwaveinthetreatmentofplantarfasciitishasobviousandstableeffectinrelievingpainandimprovingfoot-anklefunctionalactivity.[Keywords]Platelet-richplasmaExtracorporealshockwavetherapyPlantarfasciitisSodiumHyaluronateFirst-author’saddress：ShenyangOrthopaedicHospital，Shenyang110044，Chinadoi：10.3969/j.issn.1674-4985.2022.04.017足跖筋膜炎（plantarfasciitis，PF）是骨伤科门诊常见的慢性无菌性炎症，可由足跟部骨质、关节、肌腱、筋膜、滑囊等病变所引起，一般多发于40岁以上的中老年人，尤以女性患者为主[1]。临床症状表现为患侧足跟底部软组织疼痛，...